Answers are grounded in this paper and cite their sources.
Supplementary figure 2. Pathway analysis (A) Pathway analysis of SASP-related gene signature based on Protein–protein interaction network. The PPI confidence score lower than 0.9 and genes in the network with at least 5 degrees were respectively set as significant. Subsequently, the PPI network with scores> 5, node ≥ counts 5, node score = 0.2, and maximum depth = 100 as cut-off criteria. (B) Enrichment pathway of SASP-related gene signature based on GESA analysis. The human-ENSEMBLE-Gene-MsigDB chip was selected as the chip platform. FDR less than 0.05 after 1,000 random permutations were set as the cut-off criterion. (C) TNF-alpha signaling via NF-kappa B was enriched in cluster 1 of SASP-related gene signature (FDR <0.05) and G2M checkpoint enriched in cluster 2 of SASP-related gene signature (FDR <0.05) The enrichment score (y-axis) is shown. The top portion of the plot shows the ES (green line). (D) The ranked list of genes in TNF-alpha signaling via NF-kappa B of cluster1 (Right) and the ranked list of genes in the G2M checkpoint of cluster2 (Left) are shown.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: